Redhill Biopharma LTD
Tel Aviv-Yafo, Tel Aviv District
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- HaArba'a St 21, Tel Aviv-Yafo, Israel
- Website
- redhillbio.com
- Founded
- 2009
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $733,382 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Redhill biopharma LTD-opaganib as host-directed therapeutic for ebola virus disease | Office of the Assistant Secretary for Preparedness and Response | $733,382 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| ADC Therapeutics America, Inc. | New Providence, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Akanocure Pharmaceuticals Inc. | West Lafayette, IN | — |
| On Demand Pharmaceuticals Inc. | Rockville, MD | 325412 Pharmaceutical Preparation Manufacturing |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Gifford Bioscience LIMITED | England | 621511 Medical Laboratories |
About the company
Redhill Biopharma LIMITED is a for-profit, corporate entity registered in SAM.gov since July 2011, with a current registration valid through September 2025. Classified as a Subcontinent Asian (Asian-Indian) American owned business, the company appears to specialize in pharmaceutical research and development, with a particular focus on developing therapeutic interventions for complex medical conditions. The organization is a foreign-owned enterprise that provides specialized biotechnology and pharmaceutical research services to U.S. federal agencies, with a notable emphasis on developing innovative drug therapies for challenging medical challenges.
The most recent federal contract award demonstrates the company's sophisticated capabilities in medical research, specifically a $733,381.75 contract from the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR). This contract focuses on developing opaganib as a host-directed therapeutic for Ebola virus disease, highlighting Redhill Biopharma's expertise in advanced pharmaceutical research targeting critical infectious disease treatments. The contract, awarded on September 27, 2024, with a completion date of October 31, 2025, is a firm-fixed-price definitive contract that was not set aside for any special designation, indicating the company's ability to compete in open federal contracting environments.
While the provided information details only one specific federal contract, the award demonstrates Redhill Biopharma's capabilities in developing advanced pharmaceutical interventions for complex medical challenges. The contract with HHS suggests the company has significant research capabilities in developing therapeutic solutions for infectious diseases, with a particular focus on innovative drug development strategies. The company's registration in SAM.gov and its ability to secure federal contracts indicate a sophisticated understanding of federal procurement processes and the scientific expertise required to develop cutting-edge medical treatments. The contract's focus on Ebola virus disease research underscores the company's commitment to addressing critical global health challenges through advanced pharmaceutical research and development.
Quick answers
Is Redhill Biopharma LTD registered in SAM.gov?
Yes. Redhill Biopharma LTD's SAM.gov registration is active through November 2, 2027.
What is Redhill Biopharma LTD's CAGE code?
Redhill Biopharma LTD's CAGE code is 2967A, and its Unique Entity ID (UEI) is NKN1XZ8D6KG5.
How much has Redhill Biopharma LTD received in federal contracts?
Federal contracts obligated $733,382 to Redhill Biopharma LTD in fiscal years 2023 through 2027.
What is Redhill Biopharma LTD's most recent federal award?
Redhill Biopharma LTD's most recent federal contract award is Redhill biopharma LTD-opaganib as host-directed therapeutic for ebola virus disease (75A50124C00059), from Office of the Assistant Secretary for Preparedness and Response, on September 27, 2024.
On GovTribe
See Redhill Biopharma LTD's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors